114 filings
Page 2 of 6
8-K
pgugqtf2r20u1faqp
15 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
rba b7qjyu1k5bxz
19 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
h0xv7g asp0349mbnbw3
12 May 23
Baudax Bio Reports First Quarter Financial Results and Provides Business Update
8:16am
8-K
8e3 hb839u0
10 May 23
Regulation FD Disclosure
8:01am
8-K
3bgn5szj8 utgz
28 Apr 23
Entry into a Material Definitive Agreement
4:06pm
8-K
iaqu8zr op
25 Apr 23
Baudax Bio Announces Positive Top-Line Final Results
9:21am
8-K/A
g43150i hf
4 Apr 23
Entry into a Material Definitive Agreement
4:09pm
8-K
px3 a4mrkx12f31
31 Mar 23
Entry into a Material Definitive Agreement
4:50pm
8-K
1ksg823pit9byb3iyq
27 Mar 23
Baudax Bio Announces Positive Results from 2nd Interim Analysis of Phase 2 Randomized Trial for BX1000
4:05pm
8-K
w3a14l1owi aj
13 Mar 23
Regulation FD Disclosure
7:31am
8-K
77z0ngph
3 Mar 23
Other Events
8:00am
8-K
lz7i6ttv34ogcjyi
23 Feb 23
Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update
8:10am
8-K
dgo4c0
24 Jan 23
Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II
4:30pm
8-K
pbw0pv6 808
9 Jan 23
Other Events
8:14am
8-K
6iys 8jat3y0em4d
30 Dec 22
Other Events
4:05pm
8-K
stnv5dd9f3 8o7n8shz
5 Dec 22
Entry into a Material Definitive Agreement
4:34pm
8-K
ngosfy3
1 Dec 22
Entry into a Material Definitive Agreement
4:37pm
8-K
x577 qfvcd04gi09
30 Nov 22
Material Modifications to Rights of Security Holders
4:07pm
8-K
89k4eap5w
18 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
p2ppkvf03 ri4995pwk
8 Nov 22
Baudax Bio Reports Third Quarter 2022 Financial Results and Business Highlights
4:16pm